07:00 , Oct 8, 2001 |  BioCentury  |  Finance

Ebb & Flow

Whether it's a dead-cat bounce or the start of a rally, biotech has posted the best performance of the major indexes tracked by BioCentury over the past two weeks. Since Sept. 21 - the Friday...
07:00 , Oct 3, 2001 |  BC Extra  |  Financial News

Big biotech venture rounds

Three biotech venture financings of at least $20 million closed on Wednesday. Altus ( Cambridge , Mass.) raised $35 million in a private financing with Nomura International; U.S. Venture Partners; BankInvest; Clariden Bank; and other...
07:00 , Aug 15, 2001 |  BC Extra  |  Company News

Scotia's PDT assets acquired

Blue Dot Capital, a biomedical investment division of Singapore Technologies Group, acquired the photodynamic therapy (PDT) assets of Scotia Holdings (LSE:SOH), which is under administration with Ernst & Young. Blue Dot will receive all of...
07:00 , Jul 30, 2001 |  BC Extra  |  Financial News

Nereus raises $23.6 million

Nereus (San Diego, Calif.) raised $23.6 million in a venture financing. Investors included Pacific Venture Group; Novartis Bionventure Fund; China Development Industrial Bank; Blue Dot Capital; Lotus Biosciences Ventures; and Swissfirst. The company is developing...
07:00 , Jul 30, 2001 |  BioCentury  |  Finance

Ebb & Flow

After bidding up Aviron (AVIR) earlier last week, investors were forced to wait through the weekend to see the fate of their bet as the stock was halted on Thursday and Friday for the Vaccines...